Skip to main content
. 2013 Jan 18;42(3):823–830. doi: 10.3892/ijo.2013.1781

Figure 6.

Figure 6

HK-II expression in comparison with pimonidazole distribution. Representative images of (a) pimonidazole and (b) HK-II IHC staining. Typical immunostaining of pimonidazole in (c) Pimo+ and (d) Pimo−. (e) HK-II expression assessed by semiquantitative analysis in Pimo+ and Pimo−. N, necrotic/apoptotic regions.